Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results

Eur J Cardiothorac Surg. 2022 Mar 24;61(4):761-768. doi: 10.1093/ejcts/ezab421.

Abstract

Objectives: The short-term efficacy of virtual-assisted lung mapping (VAL-MAP), a preoperative bronchoscopic multi-spot lung-marking technique, has been confirmed in 2 prospective multicentre studies. The objectives of this study were to analyse the local recurrence and survival of patients enrolled in these studies, long-term.

Methods: Of the 663 patients enrolled in the 2 studies, 559 patients' follow-up data were collected. After excluding those who did not undergo VAL-MAP, whose resection was not for curative intent, who underwent concurrent resection without VAL-MAP, or who eventually underwent lobectomy instead of sublobar resection (i.e. wedge resection or segmentectomy), 422 patients were further analysed.

Results: Among 264 patients with primary lung cancer, the 5-year local recurrence-free rate was 98.4%, and the 5-year overall survival (OS) rate was 94.5%. Limited to stage IA2 or less (≤2 cm in diameter; n = 238, 90.1%), the 5-year local recurrence-free and OS rates were 98.7% and 94.8%, respectively. Among 102 patients with metastatic lung tumours, the 5-year local recurrence-free rate was 93.8% and the 5-year OS rate was 81.8%. Limited to the most common (colorectal) cancer (n = 53), the 5-year local recurrence-free and OS rates were 94.9% and 82.3%, respectively.

Conclusions: VAL-MAP, which is beneficial in localizing small barely palpable pulmonary lesions and determining the appropriate resection lines, was associated with reasonable long-term outcomes.

Subj collection: 152, 1542.

Keywords: Bronchoscopy; Ground-glass opacity; Localization; Lung cancer; Metastatic lung tumour.

MeSH terms

  • Bronchoscopy / methods
  • Humans
  • Lung / surgery
  • Lung Neoplasms*
  • Multiple Pulmonary Nodules* / surgery
  • Neoplasm Staging
  • Pneumonectomy / methods
  • Prospective Studies
  • Retrospective Studies